CAPITULO IV. LA FORMACIÓN DOCENTE
4.1.5 Competencias y desarrollo cognoscitivo
We would like to thank all the volunteers, dengue research teams at the factories and Hasan Sadikin Hospital, National Institute Health Research and Development, Ministry of Health and NAMRU#2 for their dedication in dengue research, and
to Kendra Chittenden from the USAID and INA-RESPOND for their support and assistance.
The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. Some of the authors are military service members or employees of the U.S. Government. This work was prepared as part of their official duties. Title 17 U.S.C. §105 provides that ‘Copyright protection under this title is not available for any work of the United States Government.’ Title 17 U.S.C. §101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties.
The comparison of hemagglutination inhibition test and IgG ELISA in diagnosing primary and secondary dengue infections based on plaque reduction neutralization test
89
5
References
1. WHO (2012) Dengue and Severe Dengue. World Health Organization.
2. Egger JR, Coleman PG (2007) Age and clinical dengue illness. Emerg Infect Dis 13: 924-925.
3. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496: 504-507.
4. Guy B, Almond JW (2008) Towards a dengue vaccine: progress to date and remaining challenges. Comp Immunol Microbiol Infect Dis 31: 239-252.
5. Suwandono A, Kosasih H, Kusriastuti R, Harun S, Ma’roef C, et al. (2006) Four dengue virus serotypes found circulating during an outbreak of dengue fever and dengue haemorrhagic fever in Jakarta, Indonesia, during 2004. Trans R Soc Trop Med Hyg 100: 855-862.
6. Sam SS, Omar SFS, Teoh B-T, Abd-Jamil J, AbuBakar S (2013) Review of Dengue Hemorrhagic Fever Fatal Cases Seen Among Adults: A Retrospective Study. PLoS Negl Trop Dis 7: e2194.
7. Ngwe TM, Thant KZ, Inoue S, Kurosawa Y, Lwin YY, et al. (2013) Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in Upper Myanmar. J Med Virol 85: 1258-1266. 8. Sharp TM, Hunsperger E, Santiago GA, Munoz-Jordan JL, Santiago LM, et al. (2013)
Virus-specific differences in rates of disease during the 2010 Dengue epidemic in Puerto Rico. PLoS Negl Trop Dis 7: e2159.
9. Miagostovich MP, Nogueira RM, dos Santos FB, Schatzmayr HG, Araujo ES, et al. (1999) Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis. J Clin Virol 14: 183-189.
10. Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, et al. (2003) Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diagn Lab Immunol 10: 622-630. 11. Matheus S, Deparis X, Labeau B, Lelarge. J, Morvan J (2005) Use of four dengue
virus antigens for determination of dengue immune status by enzyme-linked immunosorbent assay of immunoglobulin G avidity. J Clin Microbiol 43: 5784-5786. 12. Matheus S, Deparis X, Labeau B, Lelarge J, Morvan J, et al. (2005) Discrimination
between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample. Journal of clinical microbiology 43: 2793-2797.
seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am J Trop Med Hyg 61: 412-419. 14. A-nuegoonpipat A, Prakong S, Sa-ngasang A, Chanama S, Sawanpanyalert P, et
al. (2006) Comparison between Haemagglutination Inhibition (HI) Test and IgM and IgG-capture ELISA in Determination of Primary and Secondary Dengue Virus Infections. Dengue Bulletin 30: 141-145.
15. Lam SK, Devine PL (1998) Evaluation of capture ELISA and rapid immunochromatographic test for the determination of IgM and IgG antibodies produced during dengue infection. Clin Diagn Virol 10: 75-81.
16. Becerra A, Warke RV, de Bosch N, Rothman AL, Bosch I (2008) Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine 41: 114-120.
17. Sriprom M, Pongsumpun P, Yoksan S, Barbazan P, Gonzalez J, et al. (2003) Dengue haemorrhagic fever in Thailand, 1998-2003: primary or secondary Infection. Dengue Bulletin 27: 39-45.
18. Vaughn DW, Nisalah A, Solomon T, Kalayanarooj S, Nguyen MD (1999) Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg 60: 693-698. 19. de Souza VA, Tateno AF, Oliveira RR, Domingues RB, Araujo ES, et al. (2007) Sensitivity
and specificity of three ELISA-based assays for discriminating primary from secondary acute dengue virus infection. J Clin Virol 39: 230-233.
20. Clarke DH, Casal J (1958) Technique for Hemagglunation and Hemagglunation Inhibition with Arthropod Borne Virus. Am J Trop Med Hyg 7: 561-567.
21. WHO (1997) Dengue haemorrhagic fever: diagnosis, treatment, prevention, and control. Genevea, Switzerland: World Health Organization.
22. Morens DM, Halstead SB, Repik PM, Putvatana R, Raybourne N (1985) Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 22: 250-254.
The comparison of hemagglutination inhibition test and IgG ELISA in diagnosing primary and secondary dengue infections based on plaque reduction neutralization test
91